The survival time of patients who have received NACT is significantly different between patients with high and low expression of ASPH, and in this regard we speculated that GC patients after NACT had signs of ASPH regulating downstream signal pathways, thereby effecting Notch or SRC cascade, which are previously confirmed pathways to change malignant phenotype [30]. Here, ASPH is linked to gastric cancer.